Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Operating Expenses (2020 - 2025)

Historic Operating Expenses for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $7.1 million.

  • KORU Medical Systems' Operating Expenses rose 352.67% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 445.65%. This contributed to the annual value of $27.8 million for FY2024, which is 296.47% up from last year.
  • KORU Medical Systems' Operating Expenses amounted to $7.1 million in Q3 2025, which was up 352.67% from $6.8 million recorded in Q2 2025.
  • KORU Medical Systems' Operating Expenses' 5-year high stood at $7.3 million during Q1 2025, with a 5-year trough of $4.6 million in Q2 2021.
  • For the 5-year period, KORU Medical Systems' Operating Expenses averaged around $6.5 million, with its median value being $6.7 million (2022).
  • Examining YoY changes over the last 5 years, KORU Medical Systems' Operating Expenses showed a top increase of 7173.46% in 2021 and a maximum decrease of 2273.09% in 2021.
  • KORU Medical Systems' Operating Expenses (Quarter) stood at $5.9 million in 2021, then rose by 10.84% to $6.6 million in 2022, then dropped by 0.93% to $6.5 million in 2023, then rose by 9.56% to $7.2 million in 2024, then fell by 0.28% to $7.1 million in 2025.
  • Its Operating Expenses stands at $7.1 million for Q3 2025, versus $6.8 million for Q2 2025 and $7.3 million for Q1 2025.